Mineral Tinted Face Sunscreen Spf 30 - Medium/ Dark

Zinc Oxide And Titanium Dioxide


Unsun Cosmetics
Human Otc Drug
NDC 73455-111
Mineral Tinted Face Sunscreen Spf 30 - Medium/ Dark also known as Zinc Oxide And Titanium Dioxide is a human otc drug labeled by 'Unsun Cosmetics'. National Drug Code (NDC) number for Mineral Tinted Face Sunscreen Spf 30 - Medium/ Dark is 73455-111. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Mineral Tinted Face Sunscreen Spf 30 - Medium/ Dark drug includes Titanium Dioxide - .055 g/mL Zinc Oxide - .065 g/mL . The currest status of Mineral Tinted Face Sunscreen Spf 30 - Medium/ Dark drug is Active.

Drug Information:

Drug NDC: 73455-111
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Mineral Tinted Face Sunscreen Spf 30 - Medium/ Dark
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Zinc Oxide And Titanium Dioxide
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Unsun Cosmetics
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Cream
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:TITANIUM DIOXIDE - .055 g/mL
ZINC OXIDE - .065 g/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 15 Apr, 2019
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 04 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part352
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Unsun Cosmetics
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:15FIX9V2JP
SOI2LOH54Z
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
73455-111-301 TUBE in 1 BOX (73455-111-30) / 50 mL in 1 TUBE15 Apr, 2019N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Medicinal ingredients purpose titanium dioxide 5.5% sunscreen zinc oxide 6.5% sunscreen

Product Elements:

Mineral tinted face sunscreen spf 30 - light/ medium zinc oxide and titanium dioxide zinc oxide zinc oxide titanium dioxide titanium dioxide water coconut alkanes polyglyceryl-3 ricinoleate cocoyl caprylocaprate crambe hispanica subsp. abyssinica seed oil sorbitan sesquioleate heptyl undecylenate tan mineral tinted face sunscreen spf 30 - medium/ dark zinc oxide and titanium dioxide zinc oxide zinc oxide titanium dioxide titanium dioxide water coconut alkanes polyglyceryl-3 ricinoleate cocoyl caprylocaprate crambe hispanica subsp. abyssinica seed oil sorbitan sesquioleate heptyl undecylenate beige

Indications and Usage:

Uses helps prevent sunburn if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings:

Warnings skin cancer/skin aging alert spending time in the sun increases your risk of skin cancer and early skin aging. this product has been shown only to prevent sunburn, not skin cancer or early skin aging for external use only. do not use on damaged or broken skin. when using this product avoid contact with eyes. if contact occurs, rinse thoroughly with water. stop use and ask a doctor if rash occurs. keep out of reach of children. if swallowed, call a poison control center or get medical help right away.

Dosage and Administration:

Directions adults and children over 6 months of age: apply liberally and evenly 15 minutes before sun exposure. reapply after 80 minutes of swimming or perspiring heavily or immediately after towel drying or washing, at least every 2 hours. children under 6 months of age: ask a doctor. sun protection measures: spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with a broad spectrum spf value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m.– 2 p.m. wear long-sleeved shirts, pants, hats, and sunglasses.

Package Label Principal Display Panel:

Principal display panel - 50 ml tube label - light medium unsun ™ mineral tinted face sunscreen lotion 30 broad spectrum spf 30 water resistant (80 minutes) npn xxxxx light - medium 1.7 fl oz | 50 ml principal display panel - 50 ml tube label - light medium

Principal display panel - 50 ml tube label - medium dark unsun ™ mineral tinted face sunscreen lotion 30 broad spectrum spf 30 water resistant (80 minutes) npn xxxxx medium - dark 1.7 fl oz | 50 ml principal display panel - 50 ml tube label - medium dark


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.